Bryan Richard Hinton - 03 Nov 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Technology Officer
Signature: /s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 03 Nov 2021
Net transactions value: -$4,435
Form type: 4
Filing time: 08 Nov 2021, 16:30:40 UTC
Previous filing: 27 Oct 2021
Next filing: 30 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Options Exercise	$1,143	+106	+0.57%	$10.78	18,856	03 Nov 2021	Direct
transaction	HCAT	Common Stock	Sale	$5,578	-106	-0.56%	$52.62^*	18,750	03 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCAT	Stock Option (Right to Buy)	Options Exercise	$0	-106	-14%	$0.000000	634	03 Nov 2021	Common Stock	106	$10.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
F2	25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.